Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions
Phase 1
- Conditions
- Movement DisordersNeuro-Degenerative DiseaseParkinson DiseaseNervous System DiseasesBrain Diseases
- Interventions
- Device: Renishaw Drug Delivery System
- First Posted Date
- 2020-01-14
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Renishaw
- Target Recruit Count
- 15
- Registration Number
- NCT04228653
- Locations
- 🇸🇪
Skåne University Hospital, Lund,, Sweden
🇸🇪Karolinksa University Hospital, Stockholm, Sweden
🇫🇮Helsinki University Hospital, Helsinki, Finland
© Copyright 2025. All Rights Reserved by MedPath